Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis

Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis

Blog Article

Abstract Background This case is the first report describing rapid, successful treatment of severe atopic dermatitis (AD) and comorbid type-2 inflammatory diseases in the same UMBRELLA patient, with dupilumab treatment, with no side-effects.Case presentation We report on effects of dupilumab in a patient with severe AD, a long-standing history of a mild, perennial allergic rhino-conjunctivitis, moderate asthma and chronic rhinosinusitis with nasal polyps (CRSwNP).Conclusions Patients suffering from AD, asthma, allergic rhinitis and CRSwNP may be AEG DBE5961HG 90 cm Chimney Cooker Hood - Stainless Steel eligible for dupilumab single treatment that is possibly advantageous also from the pharmaco-economic standpoint.